Alcon stock gains as Berenberg reiterates Buy rating and 85-franc target

Published on 09/11/2026 at 14:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Alcon stock traded around CHF 54.86 on September 11, 2026 on SIX Swiss Exchange after Berenberg confirmed its Buy rating with an 85-franc price target. Analyst estimates point to 2026 earnings of 2.83 francs per share as investors focus on the eye-care group’s pipeline.

Black and white photojournalism style. Ophthalmologist using slit-lamp biomicroscope to examine patient seated in optometry chair, strong chiaroscuro contrast, documentary grain, intimate clinical moment captured in wide horizontal frame — Alcon CH0432492467: Schwarz Weiß Fotografie eines Augenarztes mit Spaltlampe und Patient im Untersuchungsstuhl, Illustration mit AI erstellt.

Alcon stock (ISIN CH0432492467) was recently quoted at around CHF 54.86 on SIX Swiss Exchange on September 11, 2026, leaving the eye-care group’s shares well below the average analyst price target but modestly higher than the morning lows. According to Zonebourse on September 11, 2026, Berenberg has reaffirmed its Buy recommendation on Alcon and kept a price target of CHF 85, highlighting the stock’s potential upside from current levels.

Analysts back Alcon with upside to targets

Berenberg describes Alcon as one of the best ways to gain exposure to the global ophthalmology market and, in its latest view published on September 11, 2026, reiterates a Buy rating with an 85-franc price objective for the shares, implying a notable gap to the last quoted levels in the mid-50s in Swiss trading. According to Finimize on September 11, 2026, Berenberg is sticking with Alcon as new products such as Unity and Tryptyr are expected to support growth, and the bank kept its CHF 85 price target after what it viewed as a solid second quarter.

The broader analyst community also sees room for the shares to rise from current levels. Data cited by Zonebourse show an average price target of USD 91.42 versus a recent close of USD 67.17 for Alcon’s listing, corresponding to a potential gain of about 36 percent if the consensus is reached. That spread underlines that the market’s current valuation reflects caution despite generally positive recommendations, with the average rating described as Buy.

Earnings expectations and latest quarterly figures

For investors tracking fundamentals, the latest available quarterly snapshot points to stable profitability. As reported by finanzen.ch on September 11, 2026, Alcon presented figures for the quarter ended June 30, 2026 on August 10, 2026, reporting earnings per share of 0.00 francs for that three-month period. While the EPS figure appears flat, analysts surveyed by finanzen.ch estimate that Alcon could earn 2.83 francs per share in the full year 2026, suggesting a significant improvement versus the quarterly run rate as costs and investments are absorbed over the year.

The implied comparison between the quarterly EPS of 0.00 francs and the full-year forecast of 2.83 francs per share indicates that most of the expected earnings are likely to be generated in the remaining quarters of 2026. According to finanzen.ch, the same analyst consensus of 2.83 francs EPS for 2026 is used by derivatives providers who structure long and short products on Alcon, reflecting that the market embeds this expectation into many trading instruments.

On the US listing, analysts also remain active. According to Yahoo Finance data for Alcon on September 10, 2026, the company’s shares closed at USD 66.55, down 2.75 percent on that session, while the average analyst price target for the US-traded shares was USD 85.24 with a high target of USD 103.00. In addition, a recent rating action on August 12, 2026 from JP Morgan maintained a Neutral stance but raised its target from USD 77.53 to USD 78.40, showing that not all analysts share Berenberg’s more optimistic view even though target levels have been nudged higher.

Same-day trading picture on SIX Swiss Exchange

Intraday on September 11, 2026, Alcon stock showed a mix of early weakness and later stabilization in its home market. Around 9:28 a.m. local time, the shares were down about 0.2 percent at CHF 54.38 on SIX Swiss Exchange, making them one of the weaker names in the Swiss Market Index at that moment, according to finanzen.ch. The intraday low in that morning dip was reported at CHF 54.36, while the shares had opened the session at CHF 54.54 with a modest trading volume.

By around 12:28 p.m. the picture had changed: Alcon stock was up about 0.7 percent at CHF 54.86 on SIX, trading near an intraday high of CHF 54.96 and ranking among the gainers in the Swiss Market Index at that time. According to finanzen.ch, the index stood around 13,828.70 points near 12:45 p.m., so Alcon’s positive move meant the stock was outperforming the broader Swiss benchmark at midday after underperforming earlier in the morning.

Looking at recent closes, Alcon finished the previous trading day on September 10, 2026 at CHF 54.50 on SIX Swiss Exchange, a decline of 2.5 percent versus the prior session with an intraday range roughly between CHF 54.40 and CHF 55.40 and volume in the mid six-figure range. This move left the shares some distance below their 52-week high while remaining well above the 52-week low, and the Swiss Market Index ended that session with only a small loss, which shows that Alcon underperformed its benchmark on that day, as reported by Ad-hoc-news.

Stock price and investor takeaway

As of the midday trading indication on September 11, 2026, Alcon stock stood at around CHF 54.86 on SIX Swiss Exchange, up about 0.7 percent from the CHF 54.50 close on September 10, 2026, with the day’s range reported between CHF 54.36 and CHF 54.96. With an average analyst target of USD 91.42 versus a recent US share price of USD 67.17 and a prominent Buy recommendation from Berenberg with a CHF 85 target, the current quotation suggests investors are still pricing in execution and competitive risks in the eye-care market even as the earnings outlook for 2026, at an expected 2.83 francs per share, points to solid profitability.